You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Join
|
Store
|
Career Center
|
Public Resources
|
Sign In
View Mobile Site
Membership
My Profile
Join the AVMA
Renew Your Membership
My AVMA Leaders
Volunteer Opportunities
Future Leaders Program
Member Community & Networking
News & Publications
Currently selected
AVMA Journals
AVMA@Work Blog
Newsletters
Hot Issues
RSS Feeds
Press Room
Professional Development
Jobs
Veterinary Salary Calculator
Personal Development
Training & Service Opportunities
Excellence in Veterinary Medicine Awards
Veterinary Education
Economics & Practice
Economics & Finance
Practice Management
Client Materials
Insurance
Advocacy
Hot Issues
National Issues
State & Local Issues
Get Involved
Meetings & Events
AVMA Convention
Veterinary Leadership Conference
Future AVMA Meeting Dates
Meetings & CE Calendar
Symposiums & Summits
Pet Health Awareness Events
About AVMA
Who We Are
Governance
AVMA Careers
AVMF
Student AVMA (SAVMA)
Allied Organizations
AVMA Store (Products)
Knowledge Base
Search the Knowledge Base
Browse AVMA Policies
Browse by Animal/Species
Browse by Topic
Browse by Discipline
Resources
Tools for K-12 Educators
You are here:
Home
|
News & Publications
|
JAVMA News
Print
Share This!
November 01, 2012
AVMA Journals
JAVMA
Scientific Articles
News Archives
News Photo Galleries
Business Classifieds
About JAVMA
AJVR
Read AJVR
About AJVR
Convention Newspaper
AVMA Collections
AVMA@Work Blog
Newsletters
Hot Issues
RSS Feeds
Press Room
November 01, 2012
JAVMANewsSubsection
Bayer to buy Teva’s U.S. animal health business
Posted Oct. 17, 2012
Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. announced Sept. 14 that they have signed an agreement for Bayer to acquire the U.S.-based animal health business of Teva for up to $145 million.
The acquisition will allow Bayer to expand its U.S. product lines for companion and food animals and will allow Teva to focus on human health. The transaction encompasses a manufacturing site in St. Joseph, Mo., and about 300 employees.
Teva’s portfolio in companion animal health includes dermatologic, wellness, and nutraceutical products. Teva’s products for food animals include anti-infectives, parasiticides, anti-inflammatories, and reproductive hormones.